vs
ARDELYX, INC.（ARDX）与PDF SOLUTIONS INC（PDFS）财务数据对比。点击上方公司名可切换其他公司
ARDELYX, INC.的季度营收约是PDF SOLUTIONS INC的1.5倍（$94.5M vs $62.4M），PDF SOLUTIONS INC净利率更高（-0.1% vs -39.8%，领先39.7%），ARDELYX, INC.同比增速更快（27.5% vs 24.6%），过去两年PDF SOLUTIONS INC的营收复合增速更高（22.9% vs 13.6%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
ARDX vs PDFS — 直观对比
营收规模更大
ARDX
是对方的1.5倍
$62.4M
营收增速更快
ARDX
高出2.9%
24.6%
净利率更高
PDFS
高出39.7%
-39.8%
两年增速更快
PDFS
近两年复合增速
13.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $62.4M |
| 净利润 | $-37.6M | $-48.0K |
| 毛利率 | — | 72.9% |
| 营业利润率 | — | 5.5% |
| 净利率 | -39.8% | -0.1% |
| 营收同比 | 27.5% | 24.6% |
| 净利润同比 | — | -108.9% |
| 每股收益（稀释后） | $-0.15 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXPDFS
| Q1 26 | $94.5M | — | ||
| Q4 25 | $125.2M | $62.4M | ||
| Q3 25 | $110.3M | $57.1M | ||
| Q2 25 | $97.7M | $51.7M | ||
| Q1 25 | $74.1M | $47.8M | ||
| Q4 24 | $116.1M | $50.1M | ||
| Q3 24 | $98.2M | $46.4M | ||
| Q2 24 | $73.2M | $41.7M |
净利润ARDXPDFS
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $-48.0K | ||
| Q3 25 | $-969.0K | $1.3M | ||
| Q2 25 | $-19.1M | $1.1M | ||
| Q1 25 | $-41.1M | $-3.0M | ||
| Q4 24 | $4.6M | $539.0K | ||
| Q3 24 | $-809.0K | $2.2M | ||
| Q2 24 | $-16.5M | $1.7M |
毛利率ARDXPDFS
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | 72.9% | ||
| Q3 25 | 96.4% | 72.3% | ||
| Q2 25 | 87.3% | 71.2% | ||
| Q1 25 | 83.4% | 72.9% | ||
| Q4 24 | 84.3% | 68.3% | ||
| Q3 24 | 84.0% | 73.1% | ||
| Q2 24 | 87.1% | 70.6% |
营业利润率ARDXPDFS
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 5.5% | ||
| Q3 25 | 4.2% | 8.5% | ||
| Q2 25 | -14.7% | 2.2% | ||
| Q1 25 | -49.0% | -7.4% | ||
| Q4 24 | 7.0% | 1.0% | ||
| Q3 24 | 2.3% | 4.6% | ||
| Q2 24 | -18.6% | 0.6% |
净利率ARDXPDFS
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | -0.1% | ||
| Q3 25 | -0.9% | 2.3% | ||
| Q2 25 | -19.5% | 2.2% | ||
| Q1 25 | -55.5% | -6.3% | ||
| Q4 24 | 4.0% | 1.1% | ||
| Q3 24 | -0.8% | 4.8% | ||
| Q2 24 | -22.5% | 4.1% |
每股收益（稀释后）ARDXPDFS
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | $0.00 | ||
| Q3 25 | $0.00 | $0.03 | ||
| Q2 25 | $-0.08 | $0.03 | ||
| Q1 25 | $-0.17 | $-0.08 | ||
| Q4 24 | $0.01 | $0.01 | ||
| Q3 24 | $0.00 | $0.06 | ||
| Q2 24 | $-0.07 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | $42.2M |
| 总债务越低越好 | $203.5M | $67.0M |
| 股东权益账面价值 | $148.6M | $271.0M |
| 总资产 | $504.5M | $418.7M |
| 负债/权益比越低杠杆越低 | 1.37× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资ARDXPDFS
| Q1 26 | $238.1M | — | ||
| Q4 25 | $68.0M | $42.2M | ||
| Q3 25 | $42.7M | $35.9M | ||
| Q2 25 | $90.0M | $40.4M | ||
| Q1 25 | $30.8M | $54.1M | ||
| Q4 24 | $64.9M | $114.9M | ||
| Q3 24 | $47.4M | $120.2M | ||
| Q2 24 | $41.9M | $117.9M |
总债务ARDXPDFS
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | $67.0M | ||
| Q3 25 | $202.1M | $67.6M | ||
| Q2 25 | $201.4M | $68.1M | ||
| Q1 25 | $151.3M | $68.7M | ||
| Q4 24 | $150.9M | — | ||
| Q3 24 | $100.7M | — | ||
| Q2 24 | $100.2M | — |
股东权益ARDXPDFS
| Q1 26 | $148.6M | — | ||
| Q4 25 | $166.9M | $271.0M | ||
| Q3 25 | $154.3M | $264.4M | ||
| Q2 25 | $139.5M | $257.5M | ||
| Q1 25 | $145.7M | $249.0M | ||
| Q4 24 | $173.3M | $246.0M | ||
| Q3 24 | $158.3M | $240.5M | ||
| Q2 24 | $147.0M | $232.2M |
总资产ARDXPDFS
| Q1 26 | $504.5M | — | ||
| Q4 25 | $501.6M | $418.7M | ||
| Q3 25 | $486.2M | $406.4M | ||
| Q2 25 | $466.8M | $391.1M | ||
| Q1 25 | $410.2M | $390.0M | ||
| Q4 24 | $435.8M | $315.3M | ||
| Q3 24 | $367.9M | $307.4M | ||
| Q2 24 | $343.5M | $298.0M |
负债/权益比ARDXPDFS
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | 0.25× | ||
| Q3 25 | 1.31× | 0.26× | ||
| Q2 25 | 1.44× | 0.26× | ||
| Q1 25 | 1.04× | 0.28× | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $17.3M |
| 自由现金流经营现金流 - 资本支出 | — | $7.5M |
| 自由现金流率自由现金流/营收 | — | 12.1% |
| 资本支出强度资本支出/营收 | — | 15.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.6M |
8季度趋势，按日历期对齐
经营现金流ARDXPDFS
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $17.3M | ||
| Q3 25 | $365.0K | $3.3M | ||
| Q2 25 | $-25.3M | $-5.2M | ||
| Q1 25 | $-38.5M | $8.6M | ||
| Q4 24 | $9.8M | $1.6M | ||
| Q3 24 | $501.0K | $9.3M | ||
| Q2 24 | $-19.4M | $684.0K |
自由现金流ARDXPDFS
| Q1 26 | — | — | ||
| Q4 25 | $20.6M | $7.5M | ||
| Q3 25 | $209.0K | $-2.9M | ||
| Q2 25 | $-26.0M | $-13.8M | ||
| Q1 25 | $-38.8M | $535.0K | ||
| Q4 24 | $9.2M | $-4.0M | ||
| Q3 24 | $364.0K | $5.1M | ||
| Q2 24 | $-19.5M | $-4.6M |
自由现金流率ARDXPDFS
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | 12.1% | ||
| Q3 25 | 0.2% | -5.1% | ||
| Q2 25 | -26.6% | -26.6% | ||
| Q1 25 | -52.3% | 1.1% | ||
| Q4 24 | 7.9% | -8.0% | ||
| Q3 24 | 0.4% | 11.0% | ||
| Q2 24 | -26.7% | -11.1% |
资本支出强度ARDXPDFS
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 15.7% | ||
| Q3 25 | 0.1% | 10.8% | ||
| Q2 25 | 0.7% | 16.5% | ||
| Q1 25 | 0.4% | 17.0% | ||
| Q4 24 | 0.5% | 11.3% | ||
| Q3 24 | 0.1% | 9.0% | ||
| Q2 24 | 0.2% | 12.8% |
现金转化率ARDXPDFS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | -4.55× | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.11× | 2.98× | ||
| Q3 24 | — | 4.20× | ||
| Q2 24 | — | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
